Nifty

:

22600.00

Sensex

:

73123.83

-87.65 (-0.39%)
-125.56 (-0.17%)

Login

Nifty
Sensex

:
:

22600.00
73123.83

-87.65 (-0.39%)
-125.56 (-0.17%)

Astrazeneca Pharma India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

62/99

BSE: 506820 | NSE: ASTRAZEN

Watchlist

NSE BSE

5988.50

23-Oct-2026

Open
High
Low
Previous Close

6060
6071.5
5850.5
6101.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

7118
42518373
9849.5
5640

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

14,970.38
88.26
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

14,521.75
0.60%
16.56

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.39
23.08
20.66

EBITDA CAGR (%)

10 Years
5 Years
3 Years

21.64
24.91
7.27

PAT CAGR (%)

10 Years
5 Years
3 Years

25.05
24.94
5.10

P:E (Median)

8 Years
5 Years
3 Years

107.16
107.86
112.08

P:BV (Average)

8 Years
5 Years
3 Years

21.13
20.84
24.63

EV:EBITDA (Average)

8 Years
5 Years
3 Years

63.65
64.30
69.39

Earnings Forecasts:

(Updated: 24-10-2026)

Description 2026 2027 2028 2029
Adj EPS 75.01 - - -
P/E Ratio 79.84 - - -
Revenue 2275.58 1390 1680 -
EBITDA 290.52 380 480 -
Net Income 187.52 230 300 -
ROA 10.69 - - -
P/B Ratio 17.15 - - -
ROE 22.82 16 17 -
FCFF 0.91 - - -
FCFF Yield 0.01 - - -
Net Debt -337.96 - - -
BVPS 349.12 - - -

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 682.79 526.31 29.73% 578.61 480.48 20.42% 611.57 440.29 38.90% 559.09 408.00 37.03%
Expenses 633.85 445.20 42.37% 517.70 394.11 31.36% 566.74 363.30 56.00% 483.91 355.46 36.14%
EBITDA 48.94 81.11 -39.66% 60.91 86.37 -29.48% 44.83 76.99 -41.77% 75.18 52.54 43.09%
EBIDTM 7.17% 15.41% 10.53% 17.98% 7.33% 17.49% 13.45% 12.88%
Other Income 9.23 11.24 -17.88% 5.95 16.15 -63.16% 5.13 7.98 -35.71% 6.17 8.15 -24.29%
Interest 1.95 0.72 170.83% 2.04 0.68 200.00% 1.06 0.33 221.21% 0.67 0.34 97.06%
Depreciation 5.23 16.57 -68.44% 5.60 17.69 -68.34% 3.84 9.07 -57.66% 2.57 9.32 -72.42%
PBT 50.75 74.70 -32.06% 58.14 78.47 -25.91% 46.54 42.02 10.76% 72.82 51.03 42.70%
Tax 12.82 18.87 -32.06% 13.26 20.22 -34.42% 13.95 11.17 24.89% 18.60 12.60 47.62%
PAT 37.93 55.83 -32.06% 44.88 58.25 -22.95% 32.59 30.85 5.64% 54.22 38.43 41.09%
PATM 5.56% 10.61% 7.76% 12.12% 5.33% 7.01% 9.70% 9.42%
EPS 15.17 22.33 -32.06% 17.95 23.30 -22.96% 13.04 12.34 5.67% 21.69 15.37 41.12%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 2,432.06 2,275.58 1,716.29 1,295.53 1,002.97 805.60 813.56 831.81 728.29 571.00 543.71 Net Sales Growth 31.10% 32.59% 32.48% 29.17% 24.50% -0.98% -2.19% 14.21% 27.55% 5.02% Cost Of Goods Sold 1,532.34 1,380.54 957.79 590.03 355.22 305.28 287.30 299.97 226.73 178.21 171.18 Gross Profit 899.72 895.04 758.50 705.50 647.75 500.32 526.26 531.84 501.56 392.79 372.53 GP Margin 36.99% 39.33% 44.19% 54.46% 64.58% 62.11% 64.69% 63.94% 68.87% 68.79% 68.52% Total Expenditure 2,202.20 2,013.55 1,462.32 1,111.08 837.85 719.42 678.09 711.11 656.99 524.71 506.77 Power & Fuel Cost - 2.88 5.30 4.87 5.54 8.10 7.37 7.72 8.27 8.30 7.68 % Of Sales - 0.13% 0.31% 0.38% 0.55% 1.01% 0.91% 0.93% 1.14% 1.45% 1.41% Employee Cost - 264.38 257.44 241.45 259.10 230.21 219.54 216.70 197.40 150.39 162.04 % Of Sales - 11.62% 15.00% 18.64% 25.83% 28.58% 26.99% 26.05% 27.10% 26.34% 29.80% Manufacturing Exp. - 112.23 48.57 89.46 76.04 57.12 49.32 40.81 49.58 50.67 36.40 % Of Sales - 4.93% 2.83% 6.91% 7.58% 7.09% 6.06% 4.91% 6.81% 8.87% 6.69% General & Admin Exp. - 81.45 75.41 66.30 56.66 40.04 40.69 65.54 74.09 46.49 55.04 % Of Sales - 3.58% 4.39% 5.12% 5.65% 4.97% 5.00% 7.88% 10.17% 8.14% 10.12% Selling & Distn. Exp. - 139.85 103.93 97.48 71.57 62.09 55.94 65.13 88.18 81.07 62.56 % Of Sales - 6.15% 6.06% 7.52% 7.14% 7.71% 6.88% 7.83% 12.11% 14.20% 11.51% Miscellaneous Exp. - 32.22 13.88 21.49 13.72 16.58 17.93 15.24 12.74 9.58 62.56 % Of Sales - 1.42% 0.81% 1.66% 1.37% 2.06% 2.20% 1.83% 1.75% 1.68% 2.18% EBITDA 229.86 262.03 253.97 184.45 165.12 86.18 135.47 120.70 71.30 46.29 36.94 EBITDA Margin 9.45% 11.51% 14.80% 14.24% 16.46% 10.70% 16.65% 14.51% 9.79% 8.11% 6.79% Other Income 26.48 28.49 40.63 34.80 26.10 14.76 12.84 12.99 16.29 12.25 14.39 Interest 5.72 4.49 1.46 1.20 0.63 0.95 1.09 1.14 0.00 0.00 0.00 Depreciation 17.24 28.58 39.99 14.94 16.26 16.95 20.13 18.58 14.92 14.74 15.83 PBT 228.25 257.45 253.15 203.11 174.33 83.04 127.09 113.97 72.67 43.80 35.50 Tax 58.63 64.68 40.62 58.03 34.81 21.44 33.79 41.76 18.22 17.89 15.45 Tax Rate 25.69% 25.65% 25.98% 26.43% 25.96% 25.82% 26.59% 36.64% 25.07% 40.84% 43.52% PAT 169.62 187.52 115.74 161.51 99.29 61.60 93.30 72.21 54.45 25.91 20.05 PAT before Minority Interest 169.62 187.52 115.74 161.51 99.29 61.60 93.30 72.21 54.45 25.91 20.05 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.97% 8.24% 6.74% 12.47% 9.90% 7.65% 11.47% 8.68% 7.48% 4.54% 3.69% PAT Growth -7.49% 62.02% -28.34% 62.66% 61.19% -33.98% 29.21% 32.62% 110.15% 29.23% EPS 67.85 75.01 46.30 64.60 39.72 24.64 37.32 28.88 21.78 10.36 8.02

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 872.79 770.35 711.92 588.69 511.39 456.17 364.44 300.80 246.93 222.87 Share Capital 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 Total Reserves 861.28 758.20 703.63 581.12 504.44 449.58 357.85 293.70 239.85 216.22 Non-Current Liabilities 394.49 159.13 97.83 68.99 73.63 44.60 44.13 22.75 109.73 88.68 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 313.62 162.24 116.30 85.97 84.91 50.50 49.47 46.11 142.28 128.90 Current Liabilities 1,109.50 908.15 467.15 484.40 392.30 373.43 367.10 267.60 218.67 202.05 Trade Payables 782.70 456.30 196.51 227.88 190.44 178.37 209.72 168.20 127.20 87.66 Other Current Liabilities 137.78 129.53 110.53 111.95 94.23 82.58 71.06 54.38 39.41 69.84 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 189.02 322.32 160.11 144.57 107.63 112.48 86.32 45.02 52.06 44.55 Total Liabilities 2,376.78 1,837.63 1,276.90 1,142.08 977.32 874.20 775.67 591.15 575.33 513.60 Net Block 117.47 64.24 66.68 68.86 74.49 80.96 71.53 74.83 75.46 86.84 Gross Block 184.76 217.61 187.13 179.12 168.83 159.78 132.84 119.83 105.85 102.57 Accumulated Depreciation 67.29 153.37 120.45 110.26 94.34 78.82 61.31 45.00 30.39 15.73 Non Current Assets 509.16 290.13 234.16 206.14 212.00 185.51 193.49 177.81 242.69 250.34 Capital Work in Progress 0.00 0.00 0.27 1.33 2.20 4.02 24.24 6.90 3.57 4.81 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 387.69 222.24 167.21 135.95 135.31 100.52 97.71 95.83 163.39 158.27 Other Non Current Assets 4.00 3.65 0.00 0.00 0.00 0.01 0.01 0.25 0.27 0.42 Current Assets 1,859.88 1,547.50 1,042.74 935.94 765.32 688.69 582.18 413.34 332.64 263.26 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 1,027.33 548.50 227.88 190.21 140.22 159.80 165.15 118.10 113.15 57.71 Sundry Debtors 213.68 184.88 153.13 107.52 85.89 85.19 83.21 79.75 54.63 43.00 Cash & Bank 448.62 536.70 505.84 500.48 448.46 352.35 252.52 173.30 125.92 115.58 Other Current Assets 170.25 16.20 13.23 13.56 90.75 91.35 81.30 42.19 38.94 46.97 Short Term Loans & Adv. 158.03 261.22 142.66 124.17 78.11 81.51 71.18 33.26 30.87 26.74 Net Current Assets 750.38 639.35 575.59 451.54 373.02 315.26 215.08 145.74 113.97 61.21 Total Assets 2,369.04 1,837.63 1,276.90 1,142.08 977.32 874.20 775.67 591.15 575.33 513.60

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity -15.14 65.36 27.87 58.29 100.80 104.78 87.42 54.98 8.79 38.10 PBT 252.20 156.36 219.54 134.10 83.04 127.09 113.97 72.67 43.80 35.50 Adjustment 33.35 76.41 -7.07 -4.80 9.66 14.20 9.75 7.62 3.39 14.61 Changes in Working Capital -217.38 -103.22 -128.17 -30.19 32.89 -3.95 -2.66 9.81 -34.25 -0.24 Cash after chg. in Working capital 68.17 129.55 84.30 99.11 125.59 137.34 121.06 90.10 12.94 49.87 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -83.31 -64.19 -56.43 -40.82 -24.79 -32.56 -33.64 -35.12 -4.15 -11.77 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 18.69 30.80 21.74 18.11 4.74 173.03 -170.80 4.28 -9.36 0.25 Net Fixed Assets 32.85 -30.21 -6.95 -9.42 -7.23 -6.72 -30.35 -17.31 -2.04 102.69 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -14.16 61.01 28.69 27.53 11.97 179.75 -140.45 21.59 -7.32 -102.44 Cash from Financing Activity -91.97 -65.59 -44.38 -24.48 -9.46 -8.97 -6.36 0.00 0.00 0.00 Net Cash Inflow / Outflow -88.42 30.57 5.23 51.92 96.08 268.84 -89.74 59.26 -0.57 38.35 Opening Cash & Equivalents 536.14 505.57 500.34 448.42 352.34 83.50 173.24 113.98 114.55 76.20 Closing Cash & Equivalent 447.72 536.14 505.57 500.34 448.42 352.34 83.50 173.24 113.98 114.55

Financial Ratios

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 346.51 305.28 283.45 234.45 203.78 181.83 145.14 119.48 97.94 88.49 ROA 8.90% 7.43% 13.35% 9.37% 6.65% 11.31% 10.57% 9.34% 4.76% 4.25% ROE 23.02% 15.73% 24.95% 18.13% 12.78% 22.83% 21.83% 20.03% 11.12% 10.63% ROCE 31.24% 21.29% 33.94% 24.49% 17.36% 31.24% 34.61% 26.53% 18.65% 18.74% Fixed Asset Turnover 11.34 8.51 7.11 5.79 4.93 5.58 6.58 6.45 5.49 3.58 Receivable days 31.88 35.81 36.53 35.03 38.57 37.62 35.75 33.67 31.15 41.96 Inventory Days 126.03 82.25 58.60 59.85 67.64 72.59 62.15 57.95 54.51 44.72 Payable days 163.79 124.39 131.27 214.92 220.48 246.52 99.66 91.40 73.21 75.53 Cash Conversion Cycle -5.88 -6.33 -36.14 -120.04 -114.26 -136.32 -1.76 0.22 12.45 11.15 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 57.17 108.10 183.95 213.86 88.41 117.60 100.97 0.00 0.00 0.00

Top Investors:

nippon life india trustee ltd-a/c nippon india small cap fund(various schemes)

tejas bhalchandra trivedi

icici prudential - various schemes

shivani t. trivedi

bandhan - various schemes

investor education and protection fund (iepf)

Annual Reports:

News Update:

Astrazeneca Pharma - Quarterly Results
11th Aug 2026, 00:00 AM

Read More
AstraZeneca Pharma gets CDSCO nod to market Enhertu for additional indication
10th Aug 2026, 12:28 PM

The receipt of this permission paves way for the marketing of Trastuzumab Deruxtecan 100mg/5mL lyophilized powder for concentrate for solution for infusion in India
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback